InvestorsHub Logo
Followers 27
Posts 744
Boards Moderated 0
Alias Born 07/12/2012

Re: None

Sunday, 07/09/2017 11:52:02 PM

Sunday, July 09, 2017 11:52:02 PM

Post# of 346050
Do not despair Brothers


The past few days have been painful...and heavy. For everyone.

But starting Monday, for every $1B that PPHM might be valued for, the share price, (as of now), = $22. (based on 45 million O/S)

I know, I know, as long as they don't dilute much more.

Hopefully, Avid profits will put a crimp on the ATM.

But the question remains:

ARE Bavi, exosome test kit, PS biomarkers, and beta-bodies worth $1B?

If they are, then your stock price = $22.

I personally think the stock is worth a lot more than that. GILD bought Pharmhasset for $12B to move along their Hep C cure. It worked.

If GILD bought PPHM for the same $12B to move along I/O, PPHM's pps would be $264.

That pps would alleviate a few headaches around here.

Except we're not talking about a Hep C cure. We're talking about kicking cancer in the can-ola.

Probably worth more than $12 B. Particularly if Bavi can triple anti-PD1 responder footprints.

Worth a LOT more.

But, our patience is once again tested. We need an exosome deal, more institutional involvement (now closer to reality, if we go above $5), and advances on those NCCN trials that, in my view, are going to make Big Pharma go berserk.

I'm hanging tough, despite the heavy rainfall. Someday the sun will come out for us.

As for right now, I realize it's been a tough camping trip.


Best to all,

Joe Six Pack







Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News